Arimoclomol citrate T40468
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
TargetMol | 生产商 | 美国 | 现货 |
性能特点
生化试剂,可用于动物细胞实验
规格 | CAS号 | 价格 | 操作 |
---|---|---|---|
25 mg | 368860-21-3 | ¥10,600.00 | 询底价 |
Product Introduction
Bioactivity
英文名: Arimoclomol citrate
描述: Arimoclomol citrate (BRX-220 citrate) is a heat shock protein (HSP) co-inducer that acts by enhancing Hsp expression and directly impacting protein aggregation, clearance of misfolded assemblies, and the proteasome-ubiquitin system. This compound is known for its ability to protect motor neurons.
体内活性: Arimoclomol (BRX-220; 20 mg/kg; orally administered for 5 d) has a protective effect against cholecystokinin-octapeptide (CCK)-induced acute pancreatitis[1]. Animal Model: Male Wistar rats weighing 240 to 270 g[1]Dosage: 20 mg/kg Administration: Administered intragastrically, for 5 days Result: Had a protective effect against CCK-induced acute pancreatitis.
存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year
关键字: BRX 220 Citrate | BRX220 Citrate | Arimoclomol Citrate | BRX-220 Citrate
Arimoclomol citrate T40468信息由TargetMol中国为您提供,如您想了解更多关于Arimoclomol citrate T40468报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途